Event

EBMT – 51st Annual Meeting

Date : March 28, 2025

Sharing of the positive topline results from our Phase 3 study in acute GvHD

For more information, visit: EBMT – 51st Annual Meeting

Kempen – Life Sciences Conference

March 31, 2025: MaaT Pharma To Present New Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies